Decoy Therapeutics Inc. (DCOY) insider trading

By person

18 insiders · 40 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Longwood Fund II, L.P. entity

10% owner

—

$2.94M (1)

−$2.94M

$0.00

−100.0%

Westphal Christoph H

10% owner

$101.73K (2)

$2.94M (1)

−$2.84M

7,153,979

$4.58M

−30.9%

Boston Foundation, Inc. entity

10% owner

—

$228.15K (2)

−$228.15K

1,600,000

$1.02M

−27.3%

Arthur David J.

Chief Executive Officer

$70.63K (11)

—

+$70.63K

554,087

$354.45K

+94.0%

Rosenblum Mark J

Chief Financial Officer

$62.05K (6)

—

+$62.05K

11,363

$7.27K

—

HANISH ARNOLD C

Director

$34.75K (6)

$17.27 (2)

+$34.73K

26,768

$17.12K

—

McVicar William K.

Director

$15.00K (2)

—

+$15.00K

29,555

$18.91K

—

Jordan Scott

Chief Business Officer

$10.17K (1)

—

+$10.17K

31,609

$20.22K

+55.6%

McCreedy Bruce J Jr.

Director

$10.01K (1)

—

+$10.01K

1,788

$1.14K

—

Northrup Jonathan P

Director

$10.01K (1)

—

+$10.01K

352,713

$225.63K

+2.5%

Burleson Tess

Director

$9.99K (2)

—

+$9.99K

2,002

$1.28K

—

McCabe John P.

Chief Financial Officer

$9.92K (1)

—

+$9.92K

1,650

$1.06K

—

Lieber Jonathan I

Director

$7.02K (1)

—

+$7.02K

2,002

$1.28K

—

PIERCE FREDERICK II

Chief Executive Officer

—

34,844

$22.29K

+2,409%

Hibner Barbara Louise

Chief Scientific Officer

—

4,216

$2.70K

—

Marschel Peter Klaus

Chief Business Officer

—

3,900

$2.49K

—

Lammers Paul

Director

—

2,001

$1.28K

—

Gauthier Patricia G.

Director

—

2,000

$1.28K

—

No percentages here. This company's share count has moved by a factor of 14.4 over the window, from 531,968 to 7,645,594 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Decoy Therapeutics Inc.

By person

Individual transactions

What was left out